Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial - Fox, Kim; Ford, Ian; Steg, Ph. Gabriel; Tendera, Michal; Robertson, Michele; Ferrari, Roberto (European heart journal, 2009)
Keywords: Adult; Angina Pectoris - drug therapy; Angina Pectoris - mortality; Anti-Arrhythmia Agents - therapeutic use; Arrhythmias, Cardiac - drug therapy; Arrhythmias, Cardiac - mortality; Benzazepines - therapeutic use; Biological and medical sciences; Cardiology. Vascular system; Coronary artery disease; Coronary Artery Disease - mortality; Coronary Artery Disease - prevention & control; Coronary heart disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Heart; Heart failure, cardiogenic pulmonary edema, cardiac enlargement; Heart rate; Hospitalization - statistics & numerical data; Humans; If inhibition; Ivabradine; Kaplan-Meier Estimate; Male; Medical sciences; Middle Aged; Myocardial Infarction - etiology; Myocardial Infarction - mortality; Prognosis; Stable angina pectoris; Ventricular Dysfunction, Left - mortality; Ventricular Dysfunction, Left - prevention & control; Young Adult; Heart rate; Stable angina pectoris; inhibition; Prognosis; Coronary artery disease; Ivabradine; Human; Cardiovascular disease; Patient; Subgroup; Heart ventricle; I; Left ventricular failure; Angina pectoris; Coronary heart disease; Randomization; Treatment; Analysis; Circulatory system; Inhibition; Cardiology; Left ventricle performance